Chiminski John R 4

What Happened
John R. Chiminski, a member of QuidelOrtho Corporation's Board of Directors, was granted a total of 22,188 restricted stock units (RSUs) on June 25, 2026. The filing shows three award line items: 15,532 RSUs, 5,547 RSUs, and 1,109 RSUs. Each RSU represents the right to receive one share of common stock; the grants are reported as derivative awards acquired at $0.00 (no cash purchase price reported).

Key Details

• Transaction date: 2026-06-25 (reported on Form 4 filed 2026-06-29). Filing appears timely.
• Transaction code: A = Award/Grant (derivative instrument, RSUs). Price reported: $0.00 (acquisition value shown as $0).
• Total RSUs granted: 22,188 (15,532 + 5,547 + 1,109).
• Vesting / release notes:
  • Footnote F1: Each RSU converts to one share upon release.
  • Footnote F2: Some RSUs (per the filing) will vest on June 25, 2027.
  • Footnote F3: RSUs were issued in lieu of cash retainer/board fees under a deferred compensation program; release of vested RSUs will follow the director’s elected deferral schedule.
  • Footnote F4 (details for the 5,547 RSU tranche): 1,386 RSUs vested on June 25, 2026; 1,387 RSUs vest on Sep 25, 2026; 1,387 on Dec 25, 2026; and 1,387 on Mar 25, 2027.
• Shares owned after the transaction: Not specified in the provided filing excerpt.

Context
These grants are awards of RSUs (not open-market purchases or sales). RSUs are a form of deferred compensation and do not represent immediate share ownership until they vest and are released according to the deferral schedule. Because these awards were issued in lieu of cash fees, they are routine compensation-related grants rather than direct open-market insider purchases or sales.